Effect of Renal Denervation on Cardiac Function and Inflammatory Factors in Heart Failure After Myocardial Infarction

Chao Li1, Wei Xia, Li Wang

  • 1Department of Cardiology, Tianjin First Central Hospital, Tianjin, China.

Insights

Renal denervation (RDN) improves cardiac function in dogs with heart failure (HF) after myocardial infarction. This procedure reduces inflammation in both heart and brain tissues, suggesting a novel therapeutic pathway for HF.

Area of Science:

  • Cardiology
  • Nephrology
  • Neuroscience

Background:

  • Heart failure (HF) impacts millions globally, with inflammation and sympathetic overactivation exacerbating post-myocardial infarction conditions.
  • Renal denervation (RDN) has shown promise in managing HF, but its precise mechanisms remain under investigation.

Purpose of the Study:

  • To investigate the efficacy of RDN in a canine model of acute myocardial infarction (AMI)-induced HF.
  • To explore the role of inflammation reduction in the central nervous system and cardiac tissue following RDN.

Main Methods:

  • A canine model of AMI-induced HF was established, with dogs randomized to control, HF, and HF + RDN groups.
  • Cardiac function, serum biomarkers, and inflammation-related protein expression in myocardial and hypothalamic tissues were assessed post-RDN.

Main Results:

  • RDN significantly improved cardiac function, evidenced by reduced left ventricular pressures and dimensions, and enhanced ejection fraction.
  • RDN treatment led to decreased expression of key inflammatory markers (interleukin-6, tumor necrosis factor-α, nuclear factor κB, monocyte chemotactic protein 1) in both cardiac and hypothalamic tissues.
  • Reduced ventricular fibrosis was observed in the RDN group.

Conclusions:

  • Renal denervation effectively improves cardiac function in a canine model of HF following AMI.
  • RDN may exert beneficial effects by modulating inflammation and central neural excitation, potentially independent of direct renal sympathetic nerve pathways.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
743
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
523
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
679
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
125
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
230